Telix Pharmaceutical...
ASX:TLX
$ 14,64
+ $1,00 (7,33%)
14,64 $
+$1,00 (7,33%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,03
Earnings Per Share
$3,54
Revenue Per Share
47,51%
Gross Margin %
$4,96 B
Market Cap
$0,59 B
Long-Term Debt
Earnings Per Share
$-0,03
Revenue Per Share
$3,54
Gross Margin %
47,51%
Market Cap
$4,96 B
Long-Term Debt
$0,59 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017
EPS Earnings Per Share $-0,03 $0,18 $0,12 $-0,28 $-0,29 $-0,17 $-0,12 $-0,07 $-0,05
Earnings Earnings $-10,16M $59,32M $38,88M $-88,68M $-89,38M $-47,67M $-30,41M $-16,01M $-9,87M
RPS Revenue Per Share $3,54 $2,38 $1,55 $0,51 $0,02 $0,02 $0,01 $0,00 $0,00
Revenue Revenue $1,20B $783,21M $502,55M $160,10M $7,60M $5,21M $3,49M $0,20M $0,00M
OCF Operating Cash Flow $25,47M $43,03M $23,90M $-63,97M $-59,33M $1,96M $0,00M $0,00M $0,00M
FCF Free Cash Flow $-11,38M $28,71M $14,15M $-73,17M $-62,05M $1,71M $0,00M $0,00M $0,00M
OM Operating Margin 3,70% 10,46% 10,33% -46,29% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 47,51% 61,79% 60,60% 59,29% 66,46% 61,17% 27,03% 100,00% 0,00%
FCFS Free Cash Flow Per Share $-0,27 $0,03 $0,04 $-0,25 $-0,21 $0,01 $-0,10 $-0,10 $-0,05
LT Debt Long-Term Debt $587,56M $551,82M $8,21M $3,31M N/A $0,10M $0,29M $0,57M N/A
Sha. Stocks 338,78M 329,55M 323,96M 316,71M 308,2M 280,41M 253,44M 228,74M 197,44M
×